HCG

Healthcare Global Enterprises Ltd.

NSE: HCG

BSE: 539787

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Hospital

631.90-15.8 (-2.43%)

8 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

46.2 / 100

Value Score

9.5 / 100

Price Momentum Score

70.0 / 100

QVM Score

30.6 / 100

Key Metrics

Market Cap

9434.39

P/E (TTM)

685.64

P/B

7.08

P/S (TTM)

3.72

EV/EBITDA

23.15

CAPE (5Y)

233.58

ROE (TTM)

1.22

ROCE (TTM)

7.19

ROA (TTM)

0.37

Avg 3Y ROE

4.00

Earnings 3Y CAGR

-22.82

Sales 3Y CAGR

14.49

Sales 5Y CAGR

20.26

Debt/Equity

1.30

Consensus TP

780.00

Strong Buy %

57.14

Promoter Holding

64.21

Pledged %

5.17

Stock Analysis

Fundamental analysis overview of Healthcare Global Enterprises Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Reasonable Debt to Equity, and decreasing

The company has reasonable Debt to Equity of 1.3 as on 31 Mar 2026 but Debt to Equity decreased by 0.69 in the last 1 year

What is Debt to Equity?

Company's earnings are of high quality

Earnings quality score of 79.2 indicates that the company's earnings are of high quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

79.2 / 100

Negative

Expensive and at a premium to industry median P/E

PE TTM of 685.64 indicates that the stock is expensive on a standalone basis and is at a 1302.7% premium to industry median P/E

What is P/E Ratio?

Median: 48.88

Value 685.64

-45.933066.63

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -3.41% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low and declining ROE

The company reported low ROE of 1.22% for 12-month ended 31 Mar 2026 and ROE declined by -385 bps from 1 year ago

What is ROE (FY)?

Low but stable operating margin

The company reported low operating margin of 8.46% for 12-month ended 31 Mar 2026 and operating margin improved marginally by 74 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth but lower than median growth of industry

The company delivered moderate revenue growth of 14.44% for 12-month ended 31 Mar 2026 but the growth was 4.37 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 18.81

Value 14.44

-17.1910376.7

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -69.22% for 12-month ended 31 Mar 2026 and the growth was 86.21 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Healthcare Global Enterprises Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Healthcare Global Enterprises Ltd. Shareholding Pattern

Quarterly breakdown of Healthcare Global Enterprises Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	23.90	23.90	66.91	66.87	70.71	68.41	68.40	71.44	71.43	71.42	71.39	71.38	71.37	71.35	71.30	71.29	71.28	71.25	71.23	71.23	71.22	62.46	63.78	63.77	64.21
Indian Promoter	23.90	23.90	16.92	16.91	17.02	14.74	14.74	14.74	14.73	13.47	13.47	13.47	13.46	10.89	10.88	10.88	10.88	10.88	10.87	10.87	10.87	11.05	9.94	9.94	9.94
Foreign Promoter	-	-	49.99	49.96	53.69	53.67	53.67	56.70	56.69	57.95	57.92	57.92	57.91	60.46	60.42	60.41	60.40	60.38	60.36	60.35	60.35	51.41	53.84	53.83	54.27
Institutions	54.70	48.62	18.62	19.65	15.96	16.11	15.40	13.62	12.85	11.77	11.29	11.57	11.91	13.05	14.22	14.82	15.26	14.84	15.93	15.71	14.92	15.38	21.95	21.52	21.66
Mutual Funds / UTI	17.56	13.79	9.68	10.12	6.86	6.76	5.20	4.57	4.14	2.94	2.81	3.01	3.87	4.56	5.67	6.38	6.49	8.73	8.94	10.04	9.19	9.43	14.63	15.08	15.31
FI/Bank/Insurance	0.00	0.02	0.00	0.91	0.96	1.10	1.08	0.96	0.76	0.62	0.62	0.40	0.40	0.37	0.57	0.28	0.14	0.16	0.19	0.22	0.48	0.67	0.61	0.54	0.58
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	25.05	22.49	7.08	6.77	6.34	6.42	7.24	7.03	6.99	7.22	7.27	7.18	6.37	6.47	6.29	6.37	6.74	3.95	4.30	2.77	2.44	2.16	3.59	3.22	2.76
Other Institutions	12.09	12.33	1.86	1.86	1.81	1.83	1.89	1.07	0.95	0.99	0.59	1.00	1.26	1.65	1.70	1.80	1.89	2.00	2.51	2.68	2.81	3.12	3.12	2.68	3.02
Non-Institution	21.40	27.48	14.47	13.48	13.33	15.48	16.19	14.94	15.73	16.81	17.31	17.04	16.72	15.59	14.48	13.89	13.46	13.90	12.83	13.06	13.86	22.16	14.27	14.71	14.13
Bodies Corporate	1.28	3.40	1.28	1.07	0.86	0.90	1.53	1.44	-	1.84	1.64	1.63	1.55	1.67	1.28	1.10	1.00	1.44	1.69	2.11	2.06	1.71	2.66	2.11	1.98
Others (incl. Retail) No. of shareholders	20.12 9,840	24.08 11,579	13.19 12,092	12.41 13,341	12.47 13,773	14.58 14,925	14.66 20,394	13.50 22,150	15.73 23,614	14.97 22,768	15.67 24,404	15.41 28,403	15.17 28,563	13.92 25,638	13.20 27,046	12.79 27,021	12.46 26,892	12.46 26,221	11.14 29,345	10.95 32,472	11.80 45,018	20.45 46,620	11.61 46,473	12.60 44,791	12.15 47,075

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Hospital	2.67%	12 / 18
2	Nifty Microcap 250	0.38%	102 / 250
3	Nifty Total Market	0.02%	546 / 749

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Healthcare Global Enterprises Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Yuva Kishore Terli Designated Person	June-2026	Market Sale (Disposal) 1st Jun 2026	0.00 %	₹ 660.00	3.00 k	₹ 19.80 lac
Punitha Rani Singh Designated Person	May-2026	Market Sale (Disposal) 29th May 2026	0.00 %	₹ 652.67	2.00 k	₹ 13.07 lac
BHARATSINH SHIVDAN GADHAVI Designated Person	March-2026	Market Sale (Disposal) 31st Mar 2026	0.12 %	₹ 519.40	13.87 k	₹ 72.04 lac
BHARATSINH S GADHAVI Designated Person	March-2026	Market Sale (Disposal) 28th Mar 2026	0.16 %	₹ 534.27	51.13 k	₹ 2.73 cr
Yuva Kishore Terli Designated Person	December-2025	Market Sale (Disposal) 30th Dec 2025	0.00 %	₹ 671.00	1.50 k	₹ 10.06 lac
Roshan Designated Person	November-2025	Market Sale (Disposal) 28th Nov 2025	0.00 %	₹ 732.33	1.51 k	₹ 11.05 lac
Ashwini P K Designated Person	September-2025	Off Market (Disposal) 30th Sep 2025	0.01 %	₹ 467.29	2.35 k	₹ 11.00 lac
Dr Deepti Gautam Tewari Designated Person	September-2025	Market Sale (Disposal) 29th Sep 2025	0.04 %	₹ 654.55	100.00	₹ 65.45 k
Dr Deepti Gautam Tewari Designated Person	September-2025	Market Sale (Disposal) 29th Sep 2025	0.04 %	₹ 650.00	7.90 k	₹ 51.35 lac
Hector Asia Holdings II Pte. Ltd. Promoter	September-2025	Off Market (Acquisition) 2nd Sep 2025	51.41 %	₹ 445.00	42.31 lac	₹ 188.27 cr

…

Corporate Actions

History of Healthcare Global Enterprises Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Rights Issue(1 new shares @ ₹512 for 17 existing shares)
Ex-date: 2nd Mar 2026Announced on: 24th Feb 2026
"Rights ISIN INE075I20017 SEDOL BWGCT95 CUSIP Y3R1XD101."

Company Profile

Overview of Healthcare Global Enterprises Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

HealthCare Global Enterprises Limited is an India-based cancer care provider. The Company offers cancer care, fertility treatment, advanced screening and diagnostic services, and tertiary care. It operates a cancer care network in India in terms of the total number of private cancer treatment center...

Key personnel

Mr. Sanjeev Kumar

Chief Financial Officer

Mr. Manu Shankar Das

Chief Marketing Officer

Ms. Sunu Manuel Abey

Compliance Officer, Company Secretary

Dr. Basavalinga Sadasivaiah AjaikumarD

Non-Independent Non-Executive Chairman of the Board

Dr. Manish MattooD

Chief Executive Officer, Executive Director

Ms. Simrun MehtaD

Non-Executive Non-Independent Director

Ms. Anjali Ajaikumar RossiD

Non-Executive Non-Independent Director

Mr. Akshay TannaD

Non-Executive Non-Independent Director

View all

Incorporated on

12 Mar 1998

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

30 Mar 2016

Free Float

4,38,39,878

Website

https://hcgel.com/

Phone no.

+918046607700

Address

Hcg Tower, No. 8, P. Kalinga Rao Road, Sampangi Rama Nagar, BANGALORE, 560027, India

Frequently Asked Questions

What is the current share price of Healthcare Global Enterprises Ltd.?

The current share price of Healthcare Global Enterprises Ltd. is ₹ 631.90 as of 8 Jul 2026.

What is the market capitalisation of Healthcare Global Enterprises Ltd.?

The market capitalisation of Healthcare Global Enterprises Ltd. stands at ₹ 9,434.39 Cr.

What is the PE ratio of Healthcare Global Enterprises Ltd.?

The Price-to-Earnings (PE) ratio of Healthcare Global Enterprises Ltd. is 685.64 as of the latest trailing twelve months data.

What is the ROE and ROCE of Healthcare Global Enterprises Ltd.?

Healthcare Global Enterprises Ltd. has a Return on Equity (ROE) of 1.22% and a Return on Capital Employed (ROCE) of 7.19% as per the latest financial reports.

What is the 52-week high and low of Healthcare Global Enterprises Ltd.?

The 52-week high of Healthcare Global Enterprises Ltd. is - and the 52-week low is -.

What is the dividend yield of Healthcare Global Enterprises Ltd.?

The dividend yield of Healthcare Global Enterprises Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Healthcare Global Enterprises Ltd.?

Foreign Institutional Investors (FII) hold 2.76%, Domestic Institutional Investors (DII) hold 15.89% and retail/public investors hold 12.15% of Healthcare Global Enterprises Ltd. shares.

What sector does Healthcare Global Enterprises Ltd. belong to?

Healthcare Global Enterprises Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Healthcare Global Enterprises Ltd. with a consensus target price of ₹ 780.00, implying 23.44% upside from current levels.

What is the beta of Healthcare Global Enterprises Ltd.?

The beta of Healthcare Global Enterprises Ltd. is 0.72, indicating its price volatility relative to the broader market. Over the past 1 year, Healthcare Global Enterprises Ltd. has delivered an absolute return of 15.48%.

What is the RSI of Healthcare Global Enterprises Ltd.?

The 14-day Relative Strength Index (RSI) of Healthcare Global Enterprises Ltd. is 51.56, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Healthcare Global Enterprises Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Healthcare Global Enterprises Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Corporate Actions

Company Profile